Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
2
×
Tags
biotech
boston blog main
boston top stories
ipo
2
×
life sciences
national blog main
national top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
san francisco
san francisco blog main
2
×
san francisco top stories
acetylon pharmaceuticals
ambys medicines
antibiotics
arvinas
astrazeneca
boston
boulder/denver
boulder/denver blog main
boulder/denver top stories
carbapenem-resistant enterobacteriaceae
celgene
cell therapy
clinical trials
constellation pharmaceuticals
deals
detroit
detroit blog main
detroit top stories
drugs
entasis therapeutics
fda
gene therapy
genentech
gritstone oncology
guardant health
holger willenbring
What
make
2
×
aiming
ambys
big
biotech
biotechs
chose
close
company
control
deadly
deal
debuted
device
diseases
firms
formed
future
ipo
ipos
launch
life
liver
medical
medicines
new
open
q
quarter
science
startup
takeda
today
treatments
unusual
variety
way
week
window
Language
Current search:
ipo
×
photo
×
" san francisco blog main "
×
make
×
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
